Lead: Nicotine e-cigarettes for cigarette smoking cessation: Recommendations to US-based clinicians

Our lead story this week is in the Journal of the American Medical Association and is titled, Nicotine E-Cigarettes for Cigarette Smoking Cessation, Recommendations to US-Based Clinicians.

This special communication summarizes the evidence on the use of e-cigarettes for smoking cessation and provides recommendations for clinicians on how to engage in conversations with adult patients who currently smoke cigarettes.

Specifically, advice is provided on one, integration of e-cigarettes into patient-centered shared decision-making conversations on the risks and benefits of various pharmacologic smoking cessation treatments, and two, practical guidance on the use of e-cigarettes for smoking cessation.

Authors include one overarching recommendation, integrate e-cigarettes into conversations on the risks and benefits of all evidence-based pharmacologic treatments for smoking cessation.

In support of this recommendation, specific guidance is provided regarding how to discuss potential misperceptions and suggested questions are offered to guide patient conversations.

Evidence-based best practices are also provided for using e-cigarettes to

quit smoking.

Our lead story this week is in the Journal of the American Medical Association and is titled, Nicotine E-Cigarettes for Cigarette Smoking Cessation, Recommendations to US-Based Clinicians.

This special communication summarizes the evidence on the use of e-cigarettes for smoking cessation and provides recommendations for clinicians on how to engage in conversations with adult patients who currently smoke cigarettes.

Specifically, advice is provided on one, integration of e-cigarettes into patient-centered shared decision-making conversations on the risks and benefits of various pharmacologic smoking cessation treatments, and two, practical guidance on the use of e-cigarettes for smoking cessation.

Authors include one overarching recommendation, integrate e-cigarettes into conversations on the risks and benefits of all evidence-based pharmacologic treatments for smoking cessation.

In support of this recommendation, specific guidance is provided regarding how to discuss potential misperceptions and suggested questions are offered to guide patient conversations.

Evidence-based best practices are also provided for using e-cigarettes to

quit smoking.